{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T05:40:49Z","timestamp":1786686049661,"version":"build-2736575974"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T00:00:00Z","timestamp":1501200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0182115","type":"journal-article","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T18:11:09Z","timestamp":1501265469000},"page":"e0182115","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib"],"prefix":"10.1371","volume":"12","author":[{"given":"Astrid","family":"Yeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7043-4865","authenticated-orcid":true,"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liling","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Aponte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4542-0784","authenticated-orcid":true,"given":"Dana","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2043-4757","authenticated-orcid":true,"given":"Karen","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"MacPhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Chissoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1680-0232","authenticated-orcid":true,"given":"Elizabeth","family":"Tarka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L.","family":"O\u2019Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey D.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0378-6531","authenticated-orcid":true,"given":"Lars","family":"Wallentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9226-1317","authenticated-orcid":true,"given":"Dawn","family":"Waterworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2174\/156800605774962103","article-title":"Lipoprotein-associated phospholipase A2: a potential therapeutic target for atherosclerosis","volume":"56","author":"A Zalewski","year":"2005","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0025-6196(11)60992-0","article-title":"Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: A systematic review","volume":"822","author":"CA Garza","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.ATV.0000160551.21962.a7","article-title":"Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target","volume":"255","author":"A Zalewski","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1161\/01.ATV.19.12.2909","article-title":"Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions","volume":"1912","author":"T H\u00e4kkinen","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/01.ATV.0000244681.72738.bc","article-title":"Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis","volume":"2611","author":"FD Kolodgie","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.108.771899","article-title":"Effects of the Direct Lipoprotein-Associated Phospholipase A<sub>2<\/sub> Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque","volume":"11811","author":"PW Serruys","year":"2008","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/nm.1870","article-title":"Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development","volume":"1410","author":"RL Wilensky","year":"2008","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1517\/13543784.14.6.671","article-title":"Lipoprotein-associated phospholipase A2: a novel marker of cardiovascular risk and potential therapeutic target","volume":"146","author":"C Macphee","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.mol.0000174155.61307.5f","article-title":"Lipoprotein-associated phospholipase A2 as a target of therapy","volume":"164","author":"CH Macphee","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1373\/clinchem.2006.070672","article-title":"Lp-PLA2: a new kid on the block","volume":"529","author":"A Zalewski","year":"2006","journal-title":"Clin Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ahj.2010.07.006","article-title":"Study design and rationale for the clinical outcomes of the STABILITY Trial STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY. comparing darapladib versus placebo in patients with coronary heart disease","volume":"1604","author":"H White","year":"2010","journal-title":"Am Heart J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ahj.2011.07.018","article-title":"Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction SOLID-TIMI 52. trial in patients after an acute coronary syndrome","volume":"1624","author":"ML O'Donoghue","year":"2011","journal-title":"Am Heart J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.2014.11061","article-title":"Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trial","volume":"31210","author":"ML O'Donoghue","year":"2014","journal-title":"JAMA"},{"key":"ref14","first-page":"1702","article-title":"Darapladib for preventing ischemic events in stable coronary heart disease","volume":"37018","author":"HD White","year":"2014","journal-title":"New Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1172\/JCI118733","article-title":"Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase","volume":"9712","author":"DM Stafforini","year":"1996","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.thromres.2010.09.009","article-title":"PLA2G7 gene polymorphisms and coronary heart disease risk: A meta-analysis","volume":"1266","author":"Q Wang","year":"2010","journal-title":"Thromb Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1007\/s11033-010-0529-9","article-title":"Lipoprotein-associated phospholipase A2 gene V279F polymorphisms and coronary heart disease: A meta-analysis","volume":"386","author":"GH Zheng","year":"2011","journal-title":"Mol Biol Rep"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e18208","DOI":"10.1371\/journal.pone.0018208","article-title":"Carriage of the V279F null allele within the gene encoding Lp-PLA2. is protective from coronary artery disease in South Korean males","volume":"64","author":"Y Jang","year":"2011","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jacc.2015.10.056","article-title":"Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults","volume":"672","author":"IY Millwood","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"ref20","article-title":"Genetic invalidation of Lp-PLA<sub>2<\/sub> as a therapeutic target: Large-scale study of five functional Lp-PLA<sub>2<\/sub>-lowering alleles","author":"JM Gregson","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e1000928","DOI":"10.1371\/journal.pgen.1000928","article-title":"Genome-wide association study of Lp-PLA2. activity and mass in the Framingham Heart Study","volume":"64","author":"S Suchindran","year":"2010","journal-title":"PLoS Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/eurheartj\/ehr372","article-title":"Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies","volume":"332","author":"H Grallert","year":"2012","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCGENETICS.112.963314","article-title":"Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy","volume":"56","author":"AY Chu","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e003407","DOI":"10.1161\/JAHA.116.003407","article-title":"Lipoprotein\u2010Associated Phospholipase A<sub>2<\/sub> Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease","volume":"5","author":"L Wallentin","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/01.CIR.98.18.1881","article-title":"Association of a G994\u2014&gt;T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese","volume":"9818","author":"S Ichihara","year":"1998","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1161\/01.STR.23.8.1090","article-title":"Platelet-activating factor acetylhydrolase in plasma lipoproteins from patients with ischemic stroke","volume":"238","author":"K Satoh","year":"1992","journal-title":"Stroke"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2003.09.019","article-title":"Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia","volume":"1721","author":"K Shimokata","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1388-1981(99)00072-4","article-title":"Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma","volume":"14391","author":"VS Subramanian","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1067\/mva.2000.105670","article-title":"Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in japan","volume":"322","author":"N Unno","year":"2000","journal-title":"J Vasc Surg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00000658-200202000-00020","article-title":"Association of a G994 \u2014&gt;T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with risk of abdominal aortic aneurysm in Japanese","volume":"2352","author":"N Unno","year":"2002","journal-title":"Ann Surg"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ajh.2009.70","article-title":"Effects of G994T in the Lp-PLA2 gene on the plasma oxidized LDL level and carotid intima-media thickness in Japanese: the Shimane study","volume":"227","author":"T Wang","year":"2009","journal-title":"Am J Hypertens"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1006\/bbrc.1997.7047","article-title":"Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281\u2014&gt;Arg mutation","volume":"2363","author":"Y Yamada","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0026-0495(98)90216-5","article-title":"Identification of the G994\u2014&gt; T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men","volume":"472","author":"Y Yamada","year":"1998","journal-title":"Metabolism"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00385-8","article-title":"Correlations between plasma platelet-activating factor acetylhydrolase PAF-AH. activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population","volume":"1501","author":"Y Yamada","year":"2000","journal-title":"Atherosclerosis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s100380170042","article-title":"Association of a G994 \u2014&gt; T Val279 \u2014&gt; Phe. polymorphism of the plasma platelet-activating factor acetylhydrolase gene with myocardial damage in Japanese patients with nonfamilial hypertrophic cardiomyopathy","volume":"468","author":"Y Yamada","year":"2001","journal-title":"J Hum Genet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1291\/hypres.30.403","article-title":"Comprehensive evaluation of genetic and environmental factors influencing the plasma lipoprotein-associated phospholipase A2 activity in a Japanese population","volume":"305","author":"SY Zhang","year":"2007","journal-title":"Hypertens Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"4667307","author":"TM Teslovich","year":"2010","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/hmg\/dds021","article-title":"The combination of a genome-wide association study of lymphocyte count and analysis of gene expression data reveals novel asthma candidate genes","volume":"219","author":"DA Cusanovich","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.1142358","article-title":"Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels","volume":"3165829","author":"R Saxena","year":"2007","journal-title":"Science"},{"issue":"SUPPL. 1","key":"ref40","article-title":"A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study","volume":"8","author":"S Kathiresan","year":"2007","journal-title":"BMC Med Genet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.291","article-title":"Common variants at 30 loci contribute to polygenic dyslipidemia","volume":"411","author":"S Kathiresan","year":"2009","journal-title":"Nat Genet"},{"key":"ref42","article-title":"Genetics of coronary artery calcification among African Americans, a meta-analysis","volume":"141","author":"MK Wojczynski","year":"2013","journal-title":"BMC Med Genet"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1000 Genomes\u2013based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"M Nikpay","year":"2015","journal-title":"Nat Genet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrg.2016.12","article-title":"The genetics of drug efficacy: opportunities and challenges","volume":"174","author":"MR Nelson","year":"2016","journal-title":"Nat Rev Genet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"813","author":"S Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","article-title":"Robust relationship inference in genome-wide association studies","volume":"2622","author":"A Manichaikul","year":"2010","journal-title":"Bioinformatics"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1093\/bioinformatics\/bts606","article-title":"A high-performance computing toolset for relatedness and principal component analysis of SNP data","volume":"2824","author":"X Zheng","year":"2012","journal-title":"Bioinformatics"},{"key":"ref48","first-page":"2543","article-title":"zCall: a rare variant caller for array-based genotyping: genetics and population analysis","volume":"2819","author":"JI Goldstein","journal-title":"Bioinformatics"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nmeth.1785","article-title":"A linear complexity phasing method for thousands of genomes","volume":"92","author":"O Delaneau","year":"2012","journal-title":"Nat Methods"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.genom.9.081307.164242","article-title":"Genotype Imputation","volume":"101","author":"Y Li","year":"2009","journal-title":"Annu Rev Genom Human Genet"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrg2796","article-title":"Genotype imputation for genome-wide association studies","volume":"117","author":"J Marchini","year":"2010","journal-title":"Nat Rev Genet"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajhg.2012.06.013","article-title":"Phasing of many thousands of genotyped samples","volume":"912","author":"AL Williams","year":"2012","journal-title":"Am J Hum Genet"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","article-title":"METAL: Fast and efficient meta-analysis of genomewide association scans","volume":"2617","author":"CJ Willer","year":"2010","journal-title":"Bioinformatics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0182115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T15:56:33Z","timestamp":1659282993000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0182115"}},"subtitle":[],"editor":[{"given":"Giuseppe Danilo","family":"Norata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,28]]},"references-count":53,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0182115","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,28]]}}}